Yuyu Pharma, Inc. (KRX:000220)
South Korea flag South Korea · Delayed Price · Currency is KRW
4,685.00
+30.00 (0.64%)
Last updated: Jul 10, 2025

Yuyu Pharma Revenue

Yuyu Pharma had revenue of 32.91B KRW in the quarter ending March 31, 2025, a decrease of -1.49%. This brings the company's revenue in the last twelve months to 132.65B, down -2.69% year-over-year. In the year 2024, Yuyu Pharma had annual revenue of 133.15B, down -2.96%.

Revenue (ttm)
132.65B
Revenue Growth
-2.69%
P/S Ratio
0.57
Revenue / Employee
502.46M
Employees
264
Market Cap
75.82B

Revenue Chart

Revenue History

Fiscal Year End Revenue Change Growth
Dec 31, 2024 133.15B -4.06B -2.96%
Dec 31, 2023 137.21B -1.67B -1.20%
Dec 31, 2022 138.88B 23.23B 20.08%
Dec 31, 2021 115.66B 17.54B 17.87%
Dec 31, 2020 98.12B 7.24B 7.97%
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Mar 31, 2017 Pro Pro Pro
Mar 31, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Samsung Biologics 4,898.69B
Celltrion 3,662.23B
ALTEOGEN 151.65B
Yuhan 2,114.76B
SK Biopharmaceuticals 578.00B
HLB Co., Ltd. 74.64B
PharmaResearch 392.31B
LigaChem Biosciences 146.42B
Revenue Rankings